In-depth analysis of Winter Coronavirus (COVID-19) Infection Study data looking at trends in self-reported symptoms of coronavirus (COVID-19), including ongoing symptoms and associated risk factors.

Technical and methodological data from the Coronavirus (COVID-19) Infection Survey, England, Wales, Northern Ireland and Scotland.

In early-February, 2020, the first cases of the coronavirus (COVID-19) were reported in the United Kingdom (UK). The number of cases in the UK has since risen to 24,243,393, with 1,062 new cases reported on January 13, 2023. The highest daily figure since the beginning of the pandemic was on January 6, 2022 at 275,646 cases.

COVID deaths in the UK COVID-19 has so far been responsible for 202,157 deaths in the UK as of January 13, 2023, and the UK has one of the highest death toll from COVID-19 in Europe. As of January 13, the incidence of deaths in the UK is 298 per 100,000 population.

Regional breakdown The South East has the highest amount of cases in the country with 3,123,050 confirmed cases as of January 11. London and the North West have 2,912,859 and 2,580,090 cases respectively.

For further information about the coronavirus (COVID-19) pandemic, please visit our dedicated Facts and Figures page.

In early-February 2020, the first cases of COVID-19 in the United Kingdom (UK) were confirmed. The number of cases in the UK increased significantly at the end of 2021. On January 13, 2023, the number of confirmed cases in the UK amounted to 24,243,393. COVID deaths among highest in Europe There were 202,157 confirmed coronavirus deaths in the UK as of January 13, 2023. For further information about the coronavirus (COVID-19) pandemic, please visit our dedicated Facts and Figures page.

Current infection rate in Europe The current infection rate in the UK was 50 cases per 100,000 population in the last seven days as of January 16. San Marino had the highest seven day rate of infections in Europe at 336.

Infectious disease is the single biggest cause of death worldwide. New infectious agents require investigation to understand its characteristics and how infection with this pathogen results in a disease process. We need to understand risk factors for severe illness and how to best treat disease caused by this pathogen. In order to develop a mechanistic understanding of disease processes, such that risk factors for severe illness can be identified and treatments can be developed, it is necessary to understand pathogen characteristics associated with virulence, the replication dynamics and in-host evolution of the pathogen, the dynamics of the host response, the pharmacology of antimicrobial or host-directed therapies, the transmission dynamics, and factors underlying individual susceptibility. This study is designed for the rapid, coordinated clinical investigation of patients with confirmed infection with a pathogen of public interest. The study has been designed to maximize the likelihood that as much data as possible is collected and shared rapidly in a format that can be easily aggregated, tabulated and analysed across many different settings globally. The study is designed to have some level of flexibility in order to ensure the broadest acceptance.

The purpose of this dataset is to understand the prevalence of the coronavirus in the UK population, using longitudinal data and including not only cross-sectional data but the inclusion of an antibody test for a sub-sample of people. Demographic information is also included allowing for analyse by different variables to identify patterns and trends.

Participants have three options open to them; can have just have one visit, can have a visit every week for a month or, can have a visit every week for a month and then continue to have visits every month for one year in total from when you joined the study. This is entirely voluntary.

At each visit a field worker conducts a questionnaire, and supervises swab tests. A proportion of visits also include a blood sample being taken. The swab and blood samples are tested at laboratories.

The overall purpose of this study is to understand how many people across the UK have or may already have had the coronavirus. This will help the government manage the pandemic moving forwards.

The COVID-19 Community Infection Survey includes information on: • how many people across England and Wales (extending to Scotland and Northern Ireland) test positive for COVID-19 at a given point in time, regardless of whether they report experiencing symptoms • the average number of new infections per week over the course of the study • the number of people who test positive for antibodies, to indicate how many people are ever likely to have had the virus • key demographic information (sex, age, occupation)

The number of new cases of HIV diagnosed in the UK fluctuated over the observed period. In 2023, there were ***** new HIV cases recorded in the UK, highest in the given period. Cases of AIDS in the UK were significantly lower, with *** cases in 2023. STIs in the UK Other common STIs in the UK are herpes, gonorrhea, and chlamydia. Especially for gonorrhea and chlamydia, an increase in cases was observed between 2012 and 2019, while in 2020 and 2021 figures fell dramatically due to the COVID-19 pandemic and resulting lockdowns and social distancing. HIV in Europe New cases of HIV in Europe amounted to roughly **** thousand in 2023, of which **** thousand were among males. Among male individuals, the most common mode of HIV transmission in Europe in 2023 was among men having homosexual intercourse.

Findings from the Coronavirus (COVID-19) Infection Survey for England.

COVID-19 is a infectious Disease which has infected more than 500 people in UK and many more people world-wide.

Acknowledgements Sincere thanks to Public Health England and Local governments. Source of Data: UK Government and Public Health UK

****Notes on the methodology**** This service shows case numbers as reported to Public Health England (PHE), matched to Administrative Geography Codes from the Office of National Statistics. Cases include people who have recovered.

Events are time-stamped on the date that PHE was informed of the new case or death.

The map shows circles that grow or shrink in line with the number of cases in that geographic area.

Data from Scotland, Wales and Northern Ireland is represented on the charts, total indicators and on the country level map layer.

Contains Ordnance Survey data © Crown copyright and database right 2020. Contains National Statistics data © Crown copyright and database right 2020.

Terms of Use No special restrictions or limitations on using the item’s content have been provided.

In early-February 2020, the first cases of COVID-19 in the United Kingdom (UK) were confirmed. As of December 2023, the South East had the highest number of confirmed first episode cases of the virus in the UK with 3,180,101 registered cases, while London had 2,947,727 confirmed first-time cases. Overall, there has been 24,243,393 confirmed cases of COVID-19 in the UK as of January 13, 2023.

COVID deaths in the UK COVID-19 was responsible for 202,157 deaths in the UK as of January 13, 2023, and the UK had the highest death toll from coronavirus in western Europe. The incidence of deaths in the UK was 297.8 per 100,000 population as January 13, 2023.

Current infection rate in Europe The infection rate in the UK was 43.3 cases per 100,000 population in the last seven days as of March 13, 2023. Austria had the highest rate at 224 cases per 100,000 in the last week.

For further information about the coronavirus (COVID-19) pandemic, please visit our dedicated Facts and Figures page.

This publication was archived on 12 October 2023. Please see the Viral Respiratory Diseases (Including Influenza and COVID-19) in Scotland publication for the latest data. This dataset provides information on number of new daily confirmed cases, negative cases, deaths, testing by NHS Labs (Pillar 1) and UK Government (Pillar 2), new hospital admissions, new ICU admissions, hospital and ICU bed occupancy from novel coronavirus (COVID-19) in Scotland, including cumulative totals and population rates at Scotland, NHS Board and Council Area levels (where possible). Seven day positive cases and population rates are also presented by Neighbourhood Area (Intermediate Zone 2011). Information on how PHS publish small are COVID figures is available on the PHS website. Information on demographic characteristics (age, sex, deprivation) of confirmed novel coronavirus (COVID-19) cases, as well as trend data regarding the wider impact of the virus on the healthcare system is provided in this publication. Data includes information on primary care out of hours consultations, respiratory calls made to NHS24, contact with COVID-19 Hubs and Assessment Centres, incidents received by Scottish Ambulance Services (SAS), as well as COVID-19 related hospital admissions and admissions to ICU (Intensive Care Unit). Further data on the wider impact of the COVID-19 response, focusing on hospital admissions, unscheduled care and volume of calls to NHS24, is available on the COVID-19 Wider Impact Dashboard. Novel coronavirus (COVID-19) is a new strain of coronavirus first identified in Wuhan, China. Clinical presentation may range from mild-to-moderate illness to pneumonia or severe acute respiratory infection. COVID-19 was declared a pandemic by the World Health Organisation on 12 March 2020. We now have spread of COVID-19 within communities in the UK. Public Health Scotland no longer reports the number of COVID-19 deaths within 28 days of a first positive test from 2nd June 2022. Please refer to NRS death certificate data as the single source for COVID-19 deaths data in Scotland. In the process of updating the hospital admissions reporting to include reinfections, we have had to review existing methodology. In order to provide the best possible linkage of COVID-19 cases to hospital admissions, each admission record is required to have a discharge date, to allow us to better match the most appropriate COVID positive episode details to an admission. This means that in cases where the discharge date is missing (either due to the patient still being treated, delays in discharge information being submitted or data quality issues), it has to be estimated. Estimating a discharge date for historic records means that the average stay for those with missing dates is reduced, and fewer stays overlap with records of positive tests. The result of these changes has meant that approximately 1,200 historic COVID admissions have been removed due to improvements in methodology to handle missing discharge dates, while approximately 820 have been added to the cumulative total with the inclusion of reinfections. COVID-19 hospital admissions are now identified as the following: A patient's first positive PCR or LFD test of the episode of infection (including reinfections at 90 days or more) for COVID-19 up to 14 days prior to admission to hospital, on the day of their admission or during their stay in hospital. If a patient's first positive PCR or LFD test of the episode of infection is after their date of discharge from hospital, they are not included in the analysis. Information on COVID-19, including stay at home advice for people who are self-isolating and their households, can be found on NHS Inform. Data visualisation of Scottish COVID-19 cases is available on the Public Health Scotland - Covid 19 Scotland dashboard. Further information on coronavirus in Scotland is available on the Scottish Government - Coronavirus in Scotland page, where further breakdown of past coronavirus data has also been published.

Based on a comparison of coronavirus deaths in 210 countries relative to their population, Peru had the most losses to COVID-19 up until July 13, 2022. As of the same date, the virus had infected over 557.8 million people worldwide, and the number of deaths had totaled more than 6.3 million. Note, however, that COVID-19 test rates can vary per country. Additionally, big differences show up between countries when combining the number of deaths against confirmed COVID-19 cases. The source seemingly does not differentiate between "the Wuhan strain" (2019-nCOV) of COVID-19, "the Kent mutation" (B.1.1.7) that appeared in the UK in late 2020, the 2021 Delta variant (B.1.617.2) from India or the Omicron variant (B.1.1.529) from South Africa.

The difficulties of death figures

This table aims to provide a complete picture on the topic, but it very much relies on data that has become more difficult to compare. As the coronavirus pandemic developed across the world, countries already used different methods to count fatalities, and they sometimes changed them during the course of the pandemic. On April 16, for example, the Chinese city of Wuhan added a 50 percent increase in their death figures to account for community deaths. These deaths occurred outside of hospitals and went unaccounted for so far. The state of New York did something similar two days before, revising their figures with 3,700 new deaths as they started to include “assumed” coronavirus victims. The United Kingdom started counting deaths in care homes and private households on April 29, adjusting their number with about 5,000 new deaths (which were corrected lowered again by the same amount on August 18). This makes an already difficult comparison even more difficult. Belgium, for example, counts suspected coronavirus deaths in their figures, whereas other countries have not done that (yet). This means two things. First, it could have a big impact on both current as well as future figures. On April 16 already, UK health experts stated that if their numbers were corrected for community deaths like in Wuhan, the UK number would change from 205 to “above 300”. This is exactly what happened two weeks later. Second, it is difficult to pinpoint exactly which countries already have “revised” numbers (like Belgium, Wuhan or New York) and which ones do not. One work-around could be to look at (freely accessible) timelines that track the reported daily increase of deaths in certain countries. Several of these are available on our platform, such as for Belgium, Italy and Sweden. A sudden large increase might be an indicator that the domestic sources changed their methodology.

Where are these numbers coming from?

The numbers shown here were collected by Johns Hopkins University, a source that manually checks the data with domestic health authorities. For the majority of countries, this is from national authorities. In some cases, like China, the United States, Canada or Australia, city reports or other various state authorities were consulted. In this statistic, these separately reported numbers were put together. For more information or other freely accessible content, please visit our dedicated Facts and Figures page.

Estimates of the prevalence of self-reported long COVID and associated activity limitation, using UK Coronavirus (COVID-19) Infection Survey data. Experimental Statistics.

This open data publication has moved to COVID-19 Statistical Data in Scotland (from 02/11/2022) Novel coronavirus (COVID-19) is a new strain of coronavirus first identified in Wuhan, China. Clinical presentation may range from mild-to-moderate illness to pneumonia or severe acute respiratory infection. This dataset provides information on demographic characteristics (age, sex, deprivation) of confirmed novel coronavirus (COVID-19) cases, as well as trend data regarding the wider impact of the virus on the healthcare system. Data includes information on primary care out of hours consultations, respiratory calls made to NHS24, contact with COVID-19 Hubs and Assessment Centres, incidents received by Scottish Ambulance Services (SAS), as well as COVID-19 related hospital admissions and admissions to ICU (Intensive Care Unit). Further data on the wider impact of the COVID-19 response, focusing on hospital admissions, unscheduled care and volume of calls to NHS24, is available on the COVID-19 Wider Impact Dashboard. There is a large amount of data being regularly published regarding COVID-19 (for example, Coronavirus in Scotland - Scottish Government and Deaths involving coronavirus in Scotland - National Records of Scotland. Additional data sources relating to this topic area are provided in the Links section of the Metadata below. Information on COVID-19, including stay at home advice for people who are self-isolating and their households, can be found on NHS Inform. All publications and supporting material to this topic area can be found in the weekly COVID-19 Statistical Report. The date of the next release can be found on our list of forthcoming publications. Data visualisation is available to view in the interactive dashboard accompanying the COVID-19 Statistical Report. Please note information on COVID-19 in children and young people of educational age, education staff and educational settings is presented in a new COVID-19 Education Surveillance dataset going forward.

These datasets comprise the main analyses for the paper “Household Transmission of Seasonal Coronavirus Infections: Results from the Flu Watch cohort study”, published in Wellcome Open Research. Details of the statistical methods are reported in the article. Datasets are given in CSV format and, where relevant, in .dta format. Descriptions for each dataset are as follows:

Household_CoV_acquired.csv/dta – data required to compute the proportion of cases presumably acquired outside of the household versus and the proportion acquired from household transmission. Each row represents an anonymised PCR-confirmed seasonal coronavirus case.

Household_CoV_TransmissionRisk.csv/dta – data required to compute the risk of symptomatic onward household transmission following a seasonal coronavirus index case, and perform stratified descriptive analyses.

Household_CoV_SAR.csv/.dta – data required to compute the seasonal coronavirus secondary attack risk overall and by strain. Each row represents an anonymised exposed-index pair from a given outbreak.

HH Transmission Serial Interval.csv – presents available, anonymised data required to compute the median clinical-onset serial interval overall and by strain for each household outbreak

Number and age distribution of Spanish and UK citizens within the overall population and within the confirmed COVID-19 cases, for Spain on May 22, 2020, and for the UK on Jun. 10, 2020.

Self-reported COVID-19 infections and other respiratory illnesses, including associated symptoms and health outcomes. Joint study with the UK Health Security Agency. These are official statistics in development.